AXONICS MODULATION TECHNOLOGIES
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
AXONICS MODULATION TECHNOLOGIES
Industry:
Health Diagnostics Medical Medical Device
Founded:
2012-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.axonics.com
Total Employee:
101+
Status:
Active
Contact:
(949) 396-6322
Total Funding:
735.64 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon DMARC Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling Japanese Yen
Similar Organizations
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Trice Medical
Trice Medical specializes in providing solutions for orthopedic diagnostics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-25 | Contura | Contura acquired by Axonics Modulation Technologies | 200 M USD |
Investors List
Gilde Healthcare
Gilde Healthcare investment in Series C - Axonics Modulation Technologies
Longitude Capital
Longitude Capital investment in Series C - Axonics Modulation Technologies
Silicon Valley Bank
Silicon Valley Bank investment in Series C - Axonics Modulation Technologies
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Axonics Modulation Technologies
Gilde Healthcare
Gilde Healthcare investment in Series C - Axonics Modulation Technologies
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Axonics Modulation Technologies
Legend Capital
Legend Capital investment in Series C - Axonics Modulation Technologies
Andera Partners
Andera Partners investment in Series C - Axonics Modulation Technologies
Advent Life Sciences
Advent Life Sciences investment in Series C - Axonics Modulation Technologies
Neomed Management
Neomed Management investment in Series C - Axonics Modulation Technologies
Official Site Inspections
http://www.axonics.com Semrush global rank: 524.17 K Semrush visits lastest month: 64 K
- Host name: 80.182.62.50.host.secureserver.net
- IP address: 50.62.182.80
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Axonics Modulation Technologies"
Axonics®, Inc.
Visit the official website for Axonics Modulation Technologies®, Inc. (NASDAQ: AXNX) to learn about the Axonics® System.See details»
Axonics® Sacral Neuromodulation Therapy
Explore Axonics® Therapy resources for healthcare professionals, including clinical outcomes, reimbursement guide, and patient education.See details»
Axonics - Org Chart, Teams, Culture & Jobs | The Org
View Axonics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Axonics - Overview, News & Similar companies | ZoomInfo.com
View Axonics (www.axonics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Events - Axonics, Inc.
The Investor Relations website contains information about Axonics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Axonics Modulation Technologies - Crunchbase
Axonics Modulation Technologies may be growing as evidenced by the acquisition agreement with Boston Scientific valued at $3.7 billion, which indicates a significant valuation and market confidence in the company's potential. The …See details»
Adoption of Charter Organization - ir.axonics.com
The Committee shall meet separately, and periodically, with management, appropriate staff of the internal audit department (or other personnel or providers responsible for the internal audit …See details»
Our Leadership Team - Axonics®
Mr. Sama brings more than 10 years of Class III medical device experience, implementing lean operations and compliant quality systems. Prior to Axonics, Mr. Sama was the Director of Operations and Quality at Vessix Vascular Inc., and …See details»
AXONICS, INC. AMENDED AND RESTATED CHARTER OF THE …
Identify individuals believed to be qualified to become Board members, consistent with the corporate governance principles of the Company and any other factors deemed appropriate, …See details»
Axonics® Advantage
At Axonics, your practice is our priority. We offer a comprehensive suite of programs and services to support you and your patients, from medical education training programs that can be tailored to your needs to proactive, long-term …See details»
Who We Are | Axonics®
Discover Axonics®, a global medical technology company specializing in bladder and bowel dysfunction treatment options. Learn about our product offerings.See details»
Committee Composition - Axonics, Inc.
The Investor Relations website contains information about Axonics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
myAxonics App | Apple and Google Play App | Axonics, Inc.
Do you suffer from Overactive Bladder, Fecal Incontinence or Urinary Retention? The myAxonics app allows patients to track their symptoms with an easy-to-use bladder and bowel diary. …See details»
Axonics® CEO Raymond W. Cohen Receives Lifetime …
Nov 30, 2021 Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder aSee details»
Important Safety Information | Axonics®
View Important Safety Information on Axonics® Therapy, including potential risks & benefits. Stay informed if considering treatment for bladder & bowel control.See details»
I. Adoption of Guidelines - ir.axonics.com
I. Adoption of Guidelines The Board of Directors (the “Board”) of Axonics, Inc. (“Axonics” or the “Company”) has adopted the following Corporate Governance Guidelines (these “Guidelines”) …See details»
Grants & Contributions - Axonics®
Sales representatives, agents or distributors may not commit Axonics support of any grant or other funding. Grant requests are reviewed by a cross-functional committee. To ensure …See details»
Investor Relations - Axonics, Inc.
Nov 14, 2020 The Investor Relations website contains information about Axonics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast …
Nov 16, 2022 Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics …See details»